Unlock instant, AI-driven research and patent intelligence for your innovation.
Medicine composition for curing tumour and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of drugs, can solve the problems of high mortality and high cost
Active Publication Date: 2013-12-25
GUIZHOU SHENQI PHARMA RES INST
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, due to the high cost of cancer treatment and the high mortality rate, many patients in less developed countries and regions will give up treatment, so the actual number of cancer patients in the world is greater than the above figures
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
[0051] The preparation process of the injection is as follows: mix the above-mentioned sodium cantharidinate, dihydroartemisinin and leopard frog enzyme, add water for injection to 1000ml, filter with a 0.45 μm microporous membrane, stir for 20 minutes to mix evenly, potting , Sterilize to obtain the injection preparation.
[0052] Usage and dosage: intravenous injection or intravenous infusion, 5-20ml each time, once a day.
[0055] The preparation process is as follows: take the above-mentioned sodium cantharidinate, dihydroartemisinin, leopard frog enzyme, 250ml of glycerin, lactose, 100g of mannitol, mix evenly, add water for injection to 1000ml, adjust the pH of the liquid to 7, filter, fill, and freeze Dry to obtain freeze-dried powder. The freeze-drying process is as follows: the filled vials are half-corked and sent to a freeze dryer, slowly frozen to below -15°C, vacuumed to 5-10Pa, and controlled to heat up at a rate of no more than 4°C / h for sublimation. After 10 hours of sublimation, set the shelf temperature to 20°C for the second drying. When the product temperature is close to the shelf temperature, dry at a constant temperature for 0.5-1 hour and then fully press the plug.
[0056] Usage and dosage: intravenous injection or intravenous drip, 0.5-5mg each time, once a day. Dissolve i...
[0059] The preparation process is as follows: mix the above-mentioned sodium cantharidinate, dihydroartemisinin and leopard frog enzyme, add 10Kg of sodium chloride and mix at the same time, add water for injection to 100L, adjust the pH to 6, filter with a 0.22μm microporous membrane, and stir for 20 Minutes to mix evenly, subpackage, and sterilize to obtain a large-volume injection.
[0060] Usage and dosage: intravenous injection or intravenous drip, 500-1000ml each time, once a day.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a medicine composition for curing tumour and a preparation method thereof, which is prepared by sodium cantharidinate, dihydroartemisinin, leopard frog enzyme and auxiliary materials. The medicine composition can improve immunity of organisms, directly kills tumour cells, is obvious in effects, is lower in toxicity and side effects compared with traditional chemoradiotherapy medicine, can serve as substitution medicine or important biological medicine for curing cancer, and brings good news to cancer patients.
Description
technical field [0001] The invention relates to a pharmaceutical composition for treating tumors and a preparation method thereof, belonging to the technical field of medicines. Background technique [0002] Tumor has always been a serious disease that endangers human health and even life. Tumor brings difficulties and physical pain to patients, and brings a series of problems and serious losses to the country. Since 1996, there have been more than 10 million newly diagnosed cancer patients worldwide each year, and more than 7 million deaths. By the end of 1999, the total number of cancer patients worldwide had exceeded 40 million. By the year 2000, according to the data of the Ministry of Health Information Center, the mortality rate of malignant tumors in cities has increased significantly, an increase of 30.24% compared with ten years ago. However, due to the high cost of cancer treatment and the high mortality rate, many patients in less developed countries and regions ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More